{"id":"CHEMBL100259","canonicalSmiles":"O=c1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"DRTQHJPVMGBUCF-XVFCMESISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"URIDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-.beta.-d-ribofuranosyluracil","NSC-20256","Uracil riboside","Uridine"],"crossReferences":{"PubChem":["26754144","8139953"],"Wikipedia":["Uridine"],"drugbank":["DB02745"],"chEBI":["16704"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL110","canonicalSmiles":"O=C(Cn1ccnc1[N+](=O)[O-])NCc1ccccc1","inchiKey":"CULUWZNBISUWAS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZNIDAZOLE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Benznidazole","Benznidazolum","Benzonidazol","NSC-299972","RO 07-1051","RO-07-1051","RO-7-1051","Radanil","Rochagan"],"crossReferences":{"DailyMed":["benznidazole"],"PubChem":["124360168","170466539","56320744"],"Wikipedia":["Benznidazole"],"drugbank":["DB11989"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 4 approved indications."}
{"id":"CHEMBL1161626","canonicalSmiles":"Cc1ccc(Nc2nccc(-c3ccnc(N4CCN(CCN)CC4)c3)n2)cc1Cl","inchiKey":"RHOOHUMOHVIXEF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1161626","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03916"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1161681","canonicalSmiles":"O=NO","inchiKey":"IOVCWXUNBOPUCH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NITROUS ACID","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Nitrite (No2-)","Nitrous acid"],"crossReferences":{"DailyMed":["sodium%20nitrite"],"Wikipedia":["Nitrous_acid"],"drugbank":["DB09112"],"chEBI":["25567"]},"childChemblIds":["CHEMBL93268","CHEMBL3186418"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for poisoning and has 18 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1164951","canonicalSmiles":"Nc1nc2c(ncn2[C@@H]2O[C@H](COP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"OCJWYBKRHNXUME-KQYNXXCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSPHOMETHYLPHOSPHONIC ACID GUANOSYL ESTER","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03486"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200329","canonicalSmiles":"Cl.Clc1ccc2nsnc2c1NC1=NCCN1","inchiKey":"ZWUKMNZJRDGCTQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIZANIDINE HYDROCHLORIDE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1079","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sirdalud","Sirdalud mr","Tizanidine hydrochloride","Zanaflex"],"synonyms":["AN-021","AN021","DS 103-282","DS-103-282","Tizanidine (as hydrochloride)","Tizanidine hcl","Tizanidine hydrochloride"],"crossReferences":{"DailyMed":["tizanidine%20hydrochloride"],"PubChem":["56320475"]},"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["HP_0001257","MONDO_0002959","HP_0003419","HP_0006986","MONDO_0043510"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for spasticity and has 3 investigational indications."}
{"id":"CHEMBL1200492","canonicalSmiles":"CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1.Cl","inchiKey":"DYCKFEBIOUQECE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NEFAZODONE HYDROCHLORIDE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL623","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dutonin","Nefazodone hydrochloride","Serzone"],"synonyms":["BMY 13754","BMY-13754","MJ 13,754-1","MJ-13754-1","NSC-760344","Nefazodone hcl","Nefazodone hydrochloride"],"crossReferences":{"DailyMed":["nefazodone%20hydrochloride"],"PubChem":["144205288","144207123","170465078","26719737","49681554"],"chEBI":["7495"]},"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546","ENSG00000102468","ENSG00000147246"],"count":4},"linkedDiseases":{"rows":["MONDO_0002009","EFO_0003761"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and is indicated for unipolar depression and major depressive disorder. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200498","canonicalSmiles":"CS(=O)(=O)O.C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H]1[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@@H]21","inchiKey":"CYETUYYEVKNSHZ-LGOOQLFJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALATROFLOXACIN MESYLATE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201197","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"," United States"],"classes":["Hepatotoxicity"],"year":2006},"tradeNames":["Trovan preservative free"],"synonyms":["517-27","Alatrofloxacin","Alatrofloxacin mesilate","Alatrofloxacin mesylate","CP-116","CP-116,517 -27","CP-116,517-27","CP-116517-27","CP-11651727"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997. It was withdrawn in European Union and  United States initially in 2006 due to Hepatotoxicity."}
{"id":"CHEMBL1200500","canonicalSmiles":"CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C","inchiKey":"KUVIULQEHSCUHY-XYWKZLDCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BECLOMETHASONE DIPROPIONATE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aerobec 100","Aerobec 50","Aerobec fte 250","Asmabec clickhaler","Asmabec spacehaler","Beclazone 100","Beclazone 100 e-breathe","Beclazone 200","Beclazone 250","Beclazone 250 e-breathe","Beclazone 50","Beclazone 50 e-breathe","Becloaqua 50","Becloforte","Becloforte e-breathe","Becloforte integra","Becloforte-vm","Beclomet diprop","Beclomet hayfever","Beclomist","Beclotaide","Beclovent","Becodisks","Beconase","Beconase aq","Becotide","Becotide 100","Becotide 100 e-breathe","Becotide 200","Becotide 50","Becotide 50 e-breathe","Clenil modulite","Clipper","Filair 100","Filair 50","Filair fte","Fostair","Fostair nexthaler","Nasobec aq","Nasobec hayfever","Propaderm","Propaderm fte","Propaderm-a","Propaderm-c","Pulvinal beclomet","Qnasl","Qvar 100","Qvar 100 e-breathe","Qvar 40","Qvar 50","Qvar 50 e-breathe","Qvar 80","Qvar redihaler","Rino clenil","Vancenase","Vancenase aq","Vancenase pockethaler","Vanceril","Vanceril double strength","Ventide","Vivabec","Zonivent aquanasal"],"synonyms":["Beclometasone","Beclometasone dipropionate","Beclomethasone","Beclomethasone dipropionate","Beclomethasone dipropionate monohydrate","NSC-755901","SCH 18020W","SCH 8020W","SCH-18020W","SGX-201","SGX-202","SGX-203"],"crossReferences":{"DailyMed":["beclomethasone%20dipropionate","beclomethasone%20dipropionate%20monohydrate"],"PubChem":["144206719","56463541"],"Wikipedia":["Beclometasone_dipropionate"],"drugbank":["DB00394"],"chEBI":["3002"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","MONDO_0013730","MONDO_0043579","EFO_0007486","EFO_0000768","EFO_1000702","EFO_1000644","HP_0001742","EFO_0004599","HP_0004798","EFO_0009715","HP_0002110","EFO_0004232","EFO_0007227","HP_0006536","Orphanet_70589","MONDO_0100096","EFO_1000391","EFO_0000544","EFO_0000702","MONDO_0004979","EFO_0000341","EFO_1001417","EFO_0003956"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and has 6 approved and 16 investigational indications."}
{"id":"CHEMBL1200666","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)/C=C/[C@@H](O)C2CC2)C[C@@H](O)C[C@@H]1O","inchiKey":"LWQQLNNNIPYSNX-UROSTWAQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIPOTRIENE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calcipotriene","Dovobet","Dovonex","Enstilar","Sorilux","Xamiol"],"synonyms":["Calcipotriene","Calcipotriene hydrate","Calcipotriene monohydrate","Calcipotriol","Calcipotriol anhydrous","Calcipotriol hydrate","Calcipotriol monohydrate","Calciptriol","MC 903","MC-903","PRI-2201"],"crossReferences":{"DailyMed":["calcipotriene","calcipotriene%20hydrate"],"PubChem":["144206022","170464710","49681738","50112719"],"drugbank":["DB02300"],"chEBI":["50749"]},"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_1001494","HP_0000964","EFO_0000701","EFO_0000676","EFO_1001993","EFO_1001361","EFO_0004208","EFO_0000274","MONDO_0043771","EFO_0000707","EFO_0003894","EFO_0002496"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for psoriasis vulgaris and psoriasis and has 10 investigational indications."}
{"id":"CHEMBL1201271","canonicalSmiles":"CC(C)(C)c1ccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)cc1","inchiKey":"MOYGZHXDRJNJEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUCLIZINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Buclizine"],"crossReferences":{"Wikipedia":["Buclizine"],"drugbank":["DB00354"],"chEBI":["3205"]},"childChemblIds":["CHEMBL2360580","CHEMBL1200403"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["MONDO_0005271"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for allergic disease."}
{"id":"CHEMBL1201352","canonicalSmiles":"C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](OC(C)=O)[C@@H](N6CCCCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(=O)CC)CCCCC1","inchiKey":"HTIKWNNIPGXLGM-YLINKJIISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAPACURONIUM","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Respiratory toxicity"],"year":2001},"tradeNames":[],"synonyms":["Rapacuronium","Rapacuronium cation","Rapacuronium ion"],"crossReferences":{"Wikipedia":["Rapacuronium"],"drugbank":["DB04834"]},"childChemblIds":["CHEMBL1200549"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1999. It was withdrawn in United States  in 2001 due to Respiratory toxicity."}
{"id":"CHEMBL1201477","drugType":"Small molecule","blackBoxWarning":false,"name":"POLYESTRADIOL PHOSPHATE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Estradurin","Polyest phos"],"synonyms":["Estradiol phosphate polymer","LEO 114","LEO-114","Polyestradiol phos phosphate","Polyestradiol phosphate"],"crossReferences":{"DrugCentral":["3482"],"Wikipedia":["Polyestradiol_phosphate"]},"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957 and is indicated for neoplasm."}
{"id":"CHEMBL1201536","drugType":"Small molecule","blackBoxWarning":false,"name":"NICOTINE POLACRILEX","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Commit","Nicorette","Nicorette (mint)","Nicotine polacrilex","Thrive"],"synonyms":["Nicotine polacrilex"],"crossReferences":{"DailyMed":["nicotine%20polacrilex"]},"linkedTargets":{"rows":["ENSG00000160716","ENSG00000101204"],"count":2},"linkedDiseases":{"rows":["EFO_0004319","MONDO_0002050","EFO_0003768","EFO_0004318"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for nicotine dependence and has 1 investigational indication."}
{"id":"CHEMBL1201607","drugType":"Antibody","blackBoxWarning":true,"name":"NATALIZUMAB","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tysabri"],"synonyms":["AN100226M","ANTEGRAN","Antegren","Natalizumab"],"crossReferences":{"DailyMed":["natalizumab"],"DrugCentral":["4970"],"Wikipedia":["Natalizumab"]},"linkedTargets":{"rows":["ENSG00000115232"],"count":1},"linkedDiseases":{"rows":["MONDO_0013730","MONDO_0005090","EFO_0000685","EFO_0000637","HP_0002140","EFO_0007323","EFO_0003929","EFO_0000540","EFO_0000384","EFO_0004599","MP_0001845","MONDO_0005301","EFO_0008520","EFO_0001378","EFO_0008522"],"count":15},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 4 approved and 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1229914","canonicalSmiles":"Cc1cn([C@H]2CC[C@@H](COP(=O)(O)O)O2)c(=O)[nH]c1=O","inchiKey":"WVNRRNJFRREKAR-JGVFFNPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1229914","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03150"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1229947","canonicalSmiles":"c1cn(CCCCCCn2ccnc2)cn1","inchiKey":"CHRPUSCNMSNSKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1229947","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06968"]},"childChemblIds":["CHEMBL3140363","CHEMBL1923931"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230670","canonicalSmiles":"CCCCC/C=C\\C=C\\[C@@H](O)CCCCCCCC(=O)O","inchiKey":"NPDSHTNEKLQQIJ-UINYOVNOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230670","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26754872"],"drugbank":["DB07302"],"chEBI":["34496"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231470","canonicalSmiles":"C=CC(C)(C)c1cc2cc3c(cc2oc1=O)O[C@H](C(C)(C)O)C3","inchiKey":"JCDLLLXYAICSQV-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHALEPIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chalepin"],"crossReferences":{"drugbank":["DB02205"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231652","canonicalSmiles":"NOCC[C@H](N)C(=O)O","inchiKey":"FQPGMQABJNQLLF-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANALINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Canaline"],"crossReferences":{"Wikipedia":["Canaline"],"drugbank":["DB02821"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233206","canonicalSmiles":"COc1cccc(-c2cccc([C@]3(C)CC(=O)N(C)C(N)=N3)c2)c1","inchiKey":"LQOCXPOKEPYGTJ-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233206","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07874"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL127516","canonicalSmiles":"CCCCOC(=O)c1ccc(N)cc1","inchiKey":"IUWVALYLNVXWKX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTAMBEN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Dermatological toxicity"," Psychiatric toxicity"],"year":1964},"tradeNames":["Butesin"],"synonyms":["Butamben","Butyl aminobenzoate","Butyl p-aminobenzoate","Butyl paba","NSC-128464","P-aminobenzoic acid butyl ester"],"crossReferences":{"PubChem":["104171291","11112245","11532999","144203943","144207576","170465735","17389507"],"Wikipedia":["Butamben"],"drugbank":["DB11148"],"chEBI":["3231"]},"childChemblIds":["CHEMBL3142541"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States  in 1964 due to Dermatological toxicity and  Psychiatric toxicity."}
{"id":"CHEMBL1455497","canonicalSmiles":"O=C(O)CC(O)C(=O)O","inchiKey":"BJEPYKJPYRNKOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MALIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Salivix"],"synonyms":["Apple acid","D,l-malic acid","Dl-malic acid","E-296","E296","FEMA NO. 2655","Hydroxybutanedioic acid","Hydroxybutanedioic acid, (-)-","Hydroxysuccinnic acid (-)","INS NO. 296","INS NO.296","INS-296","L-malate","L-malic acid","Malate","Malic acid","Malic acid l-(-)-form","Malic acid, dl-","Malic acid, l-","NSC-25941","NSC-9232","Pomalous acid"],"crossReferences":{"PubChem":["144208734","4243530"],"Wikipedia":["Malic_acid"],"drugbank":["DB12751"],"chEBI":["6650"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1500","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)CC[C@H]3[C@H]1C5","inchiKey":"IJVCSMSMFSCRME-KBQPJGBKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDROMORPHINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dihydromorphine"],"crossReferences":{"PubChem":["144206439"],"Wikipedia":["Dihydromorphine"],"drugbank":["DB01565"],"chEBI":["4575"]},"childChemblIds":["CHEMBL543073"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1554","canonicalSmiles":"Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O","inchiKey":"RJURFGZVJUQBHK-IIXSONLDSA-N","drugType":"Protein","blackBoxWarning":false,"name":"DACTINOMYCIN","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cosmegen","Cosmegen lyovac","Dactinomycin"],"synonyms":["Actinomycin c1","Actinomycin d","Actinomycin i1","Actinomycin iv","Actinomycin x1","Actinomycin-d","Dactinomycin","Dactinomycinum","Dilactone actinomycin d acid","GNF-PF-2290","GNF-Pf-1977","Meractinomycin","NCI-C04682","NSC-3053","Oncostatin k"],"crossReferences":{"DailyMed":["dactinomycin"],"PubChem":["144205550","144209680","170464668","17390061","26755269","26755270"],"Wikipedia":["Actinomycin"],"drugbank":["DB00970"],"chEBI":["27666"]},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and has 3 approved and 16 investigational indications."}
{"id":"CHEMBL157729","canonicalSmiles":"Cc1ccc2nc[nH]c2c1","inchiKey":"RWXZXCZBMQPOBF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"5-Methylbenzimidazole","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-Methylbenzimidazole"],"crossReferences":{"drugbank":["DB03177"],"chEBI":["40205"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1616433","canonicalSmiles":"CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2C(=O)[C@@H](N=CN3CCCCCC3)[C@H]2SC1(C)C","inchiKey":"NPGNOVNWUSPMDP-HLLBOEOZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1616433","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01605"],"chEBI":["51210"]},"childChemblIds":["CHEMBL1355196"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1617","canonicalSmiles":"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\\C=C\\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C","inchiKey":"NZCRJKRKKOLAOJ-XRCRFVBUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIFAXIMIN","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Normix","Rifacol","Targaxan","Xifaxan","Xifaxanta"],"synonyms":["L-105","NSC-758957","Rifamycin l 105","Rifaxidin","Rifaximin","Xifaxsan"],"crossReferences":{"DailyMed":["rifaximin"],"PubChem":["144205082"],"Wikipedia":["Rifaximin"],"drugbank":["DB01220"],"chEBI":["75246"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 3 approved and 27 investigational indications."}
{"id":"CHEMBL1648","canonicalSmiles":"COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12","inchiKey":"HMJIYCCIJYRONP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISRADIPINE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dynacirc","Dynacirc cr","Isradipine","Prescal"],"synonyms":["Isradipine","Isrodipine","NSC-759892","PN 200-110","PN-200-110"],"crossReferences":{"DailyMed":["isradipine"],"PubChem":["144204241","170465070"],"Wikipedia":["Isradipine"],"drugbank":["DB00270"]},"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000102001","ENSG00000151067"],"count":4},"linkedDiseases":{"rows":["EFO_0004319","EFO_0003890","EFO_0000289","MONDO_0005180","EFO_0003768","EFO_0000319","EFO_0005611","EFO_0000537"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and is indicated for hypertension and cardiovascular disease and has 6 investigational indications."}
{"id":"CHEMBL167911","canonicalSmiles":"COP(=O)(OC)OC=C(Cl)Cl","inchiKey":"OEBRKCOSUFCWJD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICHLORVOS","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Atgard","Equigard","Equigel","Task tabs"],"synonyms":["DDVP","Dichlorvos","NSC-6738","SD 1750","SD-1750"],"crossReferences":{"PubChem":["144204603","144208815","144211157","170466226","17389058","17389925","26752865","26752866"],"Wikipedia":["Dichlorvos"],"drugbank":["DB11397"],"chEBI":["34690"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743023","drugType":"Antibody","blackBoxWarning":false,"name":"FULRANUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 403","AMG-403","AMG403","Fulranumab","JNJ 42160443","JNJ-42160443"],"linkedTargets":{"rows":["ENSG00000134259"],"count":1},"linkedDiseases":{"rows":["EFO_1000783","HP_0012532","HP_0003419","EFO_0003843","MONDO_0005178"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1743051","drugType":"Antibody","blackBoxWarning":false,"name":"ONARTUZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["METMA-B","Metmab","Onartuzumab","PRO-143966","PRO-143996","PRO143966","RO-5490258","RO5490258"],"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0001056","MONDO_0008903","EFO_0000182","MONDO_0007254","EFO_0003060","EFO_0000519","EFO_0000311","EFO_1001951"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL1743323","canonicalSmiles":"CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1)[C@H]2O5","inchiKey":"YOYLLRBMGQRFTN-IOMBULRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORBUPRENORPHINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Norbuprenorphine"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL19","canonicalSmiles":"CC(=O)/N=c1/sc(S(N)(=O)=O)nn1C","inchiKey":"FLOSMHQXBMRNHR-QPJJXVBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHAZOLAMIDE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Methazolamide","Neptazane"],"synonyms":["L-584601","Methazolamide","Methenamide","NSC-758426","Neptazaneat","VVP-808","VVP808"],"crossReferences":{"DailyMed":["methazolamide"],"PubChem":["11112413","56422398","855821"],"Wikipedia":["Methazolamide"],"chEBI":["6822"]},"linkedTargets":{"rows":["ENSG00000167434","ENSG00000168748","ENSG00000133742","ENSG00000104267"],"count":4},"linkedDiseases":{"rows":["EFO_0004190","EFO_0009444","MONDO_0002974","EFO_1000782","EFO_0000516"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and is indicated for glaucoma and open-angle glaucoma and has 2 investigational indications."}
{"id":"CHEMBL1908351","canonicalSmiles":"Cc1cnc(NCCCN(C)C)c2c1[nH]c1ccc3cc(O)ccc3c12","inchiKey":"QROONAIPJKQFMC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INTOPLICINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Intoplicine","RP 60475","RP-60475 FREE BASE"],"crossReferences":{"drugbank":["DB12868"]},"childChemblIds":["CHEMBL1972308"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL193240","canonicalSmiles":"O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1","inchiKey":"MNDBXUUTURYVHR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROFLUMILAST","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Daliresp","Daxas"],"synonyms":["B-9302-107","B9302-107","BY-217","BY217","BYK-20869","BYK20869","Roflumilast"],"crossReferences":{"DailyMed":["roflumilast"],"PubChem":["165222658","174007051"],"Wikipedia":["Roflumilast"],"drugbank":["DB01656"],"chEBI":["47657"]},"linkedTargets":{"rows":["ENSG00000065989","ENSG00000105650","ENSG00000113448","ENSG00000184588"],"count":4},"linkedDiseases":{"rows":["Orphanet_797","MONDO_0005090","MONDO_0100130","EFO_0003095","MONDO_0002009","HP_0000726","EFO_0000401","EFO_0000464","EFO_0000618","EFO_0000274","MONDO_0004784","EFO_0001073","EFO_0000311","HP_0002110","EFO_1000760","HP_0006536","HP_0100543","EFO_0006505","MONDO_0002406","EFO_0000676","MONDO_0004979","EFO_0000574","EFO_0000341","MONDO_0005148"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and has 3 approved and 17 investigational indications."}
{"id":"CHEMBL19980","canonicalSmiles":"C[C@H]1CCC/C=C/[C@@H]2C[C@H](O)C[C@H]2[C@H](O)/C=C/C(=O)O1","inchiKey":"KQNZDYYTLMIZCT-KQPMLPITSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BREFELDIN A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["105751","26751525","396903","56422115","56463468"],"Wikipedia":["Brefeldin_A"],"drugbank":["DB07348"],"chEBI":["48080"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2037002","canonicalSmiles":"O=[N+]([O-])c1nccn1CC(O)C[18F]","inchiKey":"HIIJZYSUEJYLMX-JZRMKITLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[18F]FLUOROMISONIDAZOLE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2068841","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["[18F]-Fluoromisonidazole","[18f]fluoromisonidazole"],"crossReferences":{"drugbank":["DB14830"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL204021","canonicalSmiles":"CCN(CC)CCN(Cc1ccc(-c2ccc(C(F)(F)F)cc2)cc1)C(=O)Cn1c(SCc2ccc(F)cc2)nc(=O)c2c1CCC2","inchiKey":"WDPFJWLDPVQCAJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DARAPLADIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Darapladib","SB-480848"],"crossReferences":{"drugbank":["DB06311"]},"childChemblIds":["CHEMBL3793364"],"linkedTargets":{"rows":["ENSG00000146070"],"count":1},"linkedDiseases":{"rows":["EFO_0003914","EFO_0003770","EFO_1001461","EFO_0005672"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2103834","canonicalSmiles":"CC[C@H]1OC(=O)C[C@@H](OC(C)=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC","inchiKey":"KCJJINQANFZSAM-HZDSEHBESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TYLVALOSIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Aivlosin"],"synonyms":["Tylosin acetate isovalerte","Tylvalosin"],"crossReferences":{"drugbank":["DB11554"]},"childChemblIds":["CHEMBL2105658"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103873","canonicalSmiles":"CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1","inchiKey":"JGCMEBMXRHSZKX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MACITENTAN","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Opsumit"],"synonyms":["ACT 064992","ACT-064992","Macitentan"],"crossReferences":{"DailyMed":["macitentan"],"drugbank":["DB08932"],"chEBI":["76607"]},"linkedTargets":{"rows":["ENSG00000151617","ENSG00000136160"],"count":2},"linkedDiseases":{"rows":["MONDO_0005149","EFO_0001361","Orphanet_422","EFO_0009197","EFO_0005207","EFO_0000768","EFO_0003144","MONDO_0043839","EFO_0000717","EFO_0000519","EFO_0000537"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for idiopathic and/or familial pulmonary arterial hypertension and hypertension and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2104345","canonicalSmiles":"O=C(CCn1cnc2c(=O)[nH]cnc21)Nc1ccc(C(=O)O)cc1","inchiKey":"JMPOIZCOJJMTHI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LETEPRINIM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Leteprinim"],"childChemblIds":["CHEMBL2146108"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105060","canonicalSmiles":"CCc1cc2cc(OC)c(OC)cc2c(Cc2ccccc2)n1","inchiKey":"MYCMTMIGRXJNSO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOXAVERINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Moxaverine"],"crossReferences":{"PubChem":["170466298"],"drugbank":["DB12251"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105158","canonicalSmiles":"COc1cc(C(=O)c2ccc(Cl)cc2)cc(OC)c1OCCN1CCOCC1","inchiKey":"KVCJCEKJKGLBOK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MORCLOFONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Morclofone","Plausitin"],"crossReferences":{"drugbank":["DB13558"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105552","canonicalSmiles":"C=CC1(C(C)CCC)C(=O)NC(=O)NC1=O","inchiKey":"KGKJZEKQJQQOTD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VINYLBITAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butylvinal","Butyvinyl","JD-96","Optanox","Speda","Vinylbital","Vinylbitone","Vinymal"],"crossReferences":{"drugbank":["DB13770"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105682","canonicalSmiles":"CN1CCc2nc(C(=O)N[C@@H]3C[C@@H](C(=O)N(C)C)CC[C@@H]3NC(=O)C(=O)Nc3ccc(Cl)cn3)sc2C1.Cc1ccc(S(=O)(=O)O)cc1","inchiKey":"ZLFZITWZOYXXAW-QXXZOGQOSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"EDOXABAN TOSYLATE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1269025","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Savaysa"],"synonyms":["DU-176B","Edoxaban tosilate","Edoxaban tosylate"],"crossReferences":{"DailyMed":["edoxaban%20tosylate"],"chEBI":["85975"]},"linkedTargets":{"rows":["ENSG00000126218"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","MONDO_0000831","EFO_0003827","EFO_0000712","EFO_0004286","EFO_0003907"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 4 approved and 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2105698","canonicalSmiles":"CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1.Cl","inchiKey":"LGMSNQNWOCSPIK-LWHGMNCYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALVOCIDIB HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL428690","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alvocidib hydrochloride","Flavopiridol hydrochloride","HL 275","HMR 1275","L 86 8275","L-86-8275","MDL-107826A"],"crossReferences":{"PubChem":["144206947","170466414"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2105735","canonicalSmiles":"C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2ncc(OC)c3ccc(Cl)cc23)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1","inchiKey":"XRWSZZJLZRKHHD-WVWIJVSJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASUNAPREVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Asunaprevir","BMS 650032","BMS-650032","Sunvepra"],"crossReferences":{"drugbank":["DB11586"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2107757","canonicalSmiles":"N#CCC/C(O)=C(\\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1","inchiKey":"OQUXVPJVBSENGK-QXMHVHEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MANITIMUS","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FK-778","FK778","Fk778","HMR 1715","HMR-1715","MNA-715","Manitimus"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108047","drugType":"Unknown","blackBoxWarning":false,"name":"RINFABATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RHIGFBP-3","Rinfabate"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108505","drugType":"Enzyme","blackBoxWarning":false,"name":"LACTASE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Beta-galactosidase (aspergillus)","G9S0VV191I","Lactase"],"description":"Enzyme drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108712","drugType":"Small molecule","blackBoxWarning":false,"name":"PLOVAMER ACETATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CO-14","PI-2301","Pi-2301 acetate","Plovamer acetate"],"linkedTargets":{"rows":["ENSG00000196126"],"count":1},"linkedDiseases":{"rows":["EFO_0003929"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109421","drugType":"Antibody","blackBoxWarning":false,"name":"4B5","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4B5","4b5"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109568","drugType":"Antibody","blackBoxWarning":false,"name":"HNK20","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HNK20"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2110814","canonicalSmiles":"CNCCC(c1cccc(F)c1)c1cccc(F)c1","inchiKey":"MUGNLPWYHGOJEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DELUCEMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Delucemine"],"childChemblIds":["CHEMBL2106165"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2111110","canonicalSmiles":"C1CCC2(C1)[C@H]1CN(CC3CC3)C[C@@H]2CN(CC2CC2)C1","inchiKey":"CTIRHWCPXYGDGF-HDICACEKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEDISAMIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KC-8857","KC8857","Tedisamil"],"childChemblIds":["CHEMBL2107378"],"linkedTargets":{"rows":["ENSG00000164794","ENSG00000116396","ENSG00000184408","ENSG00000162975","ENSG00000171126","ENSG00000177272","ENSG00000168263","ENSG00000053918","ENSG00000129159","ENSG00000140015","ENSG00000026559","ENSG00000143105","ENSG00000182674","ENSG00000173826","ENSG00000184156","ENSG00000185760","ENSG00000124134","ENSG00000183960","ENSG00000111262","ENSG00000102057","ENSG00000178342","ENSG00000055118","ENSG00000117013","ENSG00000170745","ENSG00000130037","ENSG00000131398","ENSG00000182255","ENSG00000075043","ENSG00000143473","ENSG00000177301","ENSG00000158445","ENSG00000168418","ENSG00000135519","ENSG00000089558","ENSG00000151079","ENSG00000166006","ENSG00000104848","ENSG00000156486","ENSG00000171385","ENSG00000184611"],"count":40},"linkedDiseases":{"rows":["EFO_0003911","EFO_0000275","EFO_0004269"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2111157","canonicalSmiles":"CCC(=O)C(CC(C)N1CCCCC1)(c1ccccc1)c1ccccc1","inchiKey":"SVDHSZFEQYXRDC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPIPANONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Acscn-9622","Dipipanone","IDS-ND-017","Phenylpiperone","Piperidylamidone"],"crossReferences":{"drugbank":["DB01491"]},"childChemblIds":["CHEMBL2107606"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2178575","canonicalSmiles":"COc1cccc2c1c(NS(=O)(=O)c1ccc(Cl)s1)nn2Cc1cccc(NC(=O)CO)c1","inchiKey":"JVBQEIRQUCWMTR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-2239633","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK 2239633A","GSK2239633","Gsk-2239633","Gsk-2239633a"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2206196","canonicalSmiles":"NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O.O=S(=O)(O)O","inchiKey":"LJRDOKAZOAKLDU-UDXJMMFXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAROMOMYCIN SULFATE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL370143","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gabbroral","Humatin","Paromomycin sulfate"],"synonyms":["Aminosidine sulfate","Crestomycin sulfate","Estomycin sulfate","NSC-758421","Paromomycin sulfate"],"crossReferences":{"DailyMed":["paromomycin%20sulfate"],"PubChem":["144205902"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1969 and is indicated for infection and amebiasis and has 3 investigational indications."}
{"id":"CHEMBL255231","canonicalSmiles":"C#CCN[C@@H]1CCc2ccc(OC(=O)N(C)CC)cc21","inchiKey":"LHXOCOHMBFOVJS-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LADOSTIGIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ladostigil","TV-3326 FREE BASE"],"childChemblIds":["CHEMBL2448610","CHEMBL1788299"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL265948","canonicalSmiles":"Nc1nc2c(ncn2/C=C2/CC2(CO)CO)c(=O)[nH]1","inchiKey":"KMUNHOKTIVSFRA-KXFIGUGUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FILOCICLOVIR","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyclopropavir","Filociclovir","MBX-400","ZSM-162","ZSM-I 62","ZSM-I62"],"crossReferences":{"drugbank":["DB12438"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL270672","canonicalSmiles":"Cc1cc(=O)oc2cc(N)ccc12","inchiKey":"GLNDAGDHSLMOKX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL270672","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["3717444"],"drugbank":["DB08168"],"chEBI":["51771"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL27759","canonicalSmiles":"Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1","inchiKey":"INVTYAOGFAGBOE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENTINOSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Entinostat","MS-27-275","MS-275","MS-275-27","SNDX-275"],"crossReferences":{"PubChem":["137275820","29217590","529250"],"Wikipedia":["Entinostat"],"drugbank":["DB11841"]},"childChemblIds":["CHEMBL3093129"],"linkedTargets":{"rows":["ENSG00000108840","ENSG00000094631","ENSG00000061273","ENSG00000163517","ENSG00000068024","ENSG00000116478","ENSG00000147099","ENSG00000100429","ENSG00000171720","ENSG00000048052","ENSG00000196591"],"count":11},"linkedDiseases":{"rows":["EFO_0009878","EFO_0003086","EFO_0003869","EFO_1001901","EFO_0000756","EFO_0000681","EFO_1000657","MONDO_0007254","MONDO_0021063","MONDO_0002087","MONDO_0003541","EFO_0000305","MONDO_0001187","EFO_1001951","MONDO_0002158","EFO_0000673","EFO_0000326","EFO_0000183","EFO_0000198","EFO_0000616","EFO_0002618","EFO_1000616","MONDO_0008170","EFO_0000349","EFO_0000222","EFO_0003060","EFO_0000311","EFO_0000304","EFO_0006861","EFO_0005537","EFO_0000574","MONDO_0002367","MONDO_0024880","EFO_1000233"],"count":34},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 28 investigational indications."}
{"id":"CHEMBL281795","canonicalSmiles":"CC(C)C[C@H](CC(=O)NO)C(=O)N[C@H]1Cc2cn(c3ccccc23)CCCCCCNC1=O","inchiKey":"GCBPAPVOMPJQHK-NQIIRXRSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL281795","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08489"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL298359","canonicalSmiles":"COC1=C(C)C(=O)C2=C(C1=O)[C@@H](COC(N)=O)[C@@]1(OC)[C@H]3N[C@H]3CN21","inchiKey":"HYFMSAFINFJTFH-NGSRAFSJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MITOMYCIN A","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["6-methoxy analog of mitomycin c","Mitomycin a","NSC-75986"],"crossReferences":{"chEBI":["85412"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3039528","canonicalSmiles":"CN1CCN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CC1(C)C","inchiKey":"BYPMJBXPNZMNQD-PZJWPPBQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZICRONAPINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LU-31-130","Lu 31-130","Zicronapine"],"crossReferences":{"drugbank":["DB12188"]},"childChemblIds":["CHEMBL3039534"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3114577","canonicalSmiles":"NCC(=O)Nc1cncc(-c2nn3c(=O)cc(N4CCNCC4)nc3s2)c1","inchiKey":"LTVKZVGAALCRFW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZALUNFIBAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RUC-4","Zalunfiban"],"childChemblIds":["CHEMBL4802247"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3137330","canonicalSmiles":"C[C@H]1CO[C@@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c([O-])c3C(=O)N12.[Na+]","inchiKey":"AEZBWGMXBKPGFP-KIUAEZIZSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CABOTEGRAVIR SODIUM","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2403238","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vocabria"],"synonyms":["Cabotegravir sodium","GSK-1265744B","GSK1265744B","S-265744B"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and is indicated for hiv-1 infection and has 1 investigational indication."}
{"id":"CHEMBL3183968","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(CSc3nc(=O)c([O-])nn3C)CS[C@H]12)c1csc(N)n1.O.O.O.[Na+].[Na+]","inchiKey":"XMCDZRXQAGFWAK-PMCOHIMVSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTRIAXONE SODIUM","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL161","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ceftriaxone","Rocephin"],"synonyms":["Cefraden","Ceftriaxone (as sodium)","Ceftriaxone disodium salt","Ceftriaxone disodium salt hemiheptahydrate","Ceftriaxone sodium","Ceftriaxone sodium anhydrous","Ceftriaxone sodium hydrate","Ceftriaxone sodium sesquaterhydrate","Megion","RO 13-9904","RO-13-9904","Rocefin","Sodium ceftriaxone, anhydrous"],"crossReferences":{"DailyMed":["ceftriaxone%20sodium"],"PubChem":["144204939","170465387"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and has 8 approved and 1 investigational indication."}
{"id":"CHEMBL31965","canonicalSmiles":"C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1","inchiKey":"OMZCMEYTWSXEPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANERTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CI-1033","Canertinib"],"crossReferences":{"PubChem":["124894124","144206912","174006548","50100094"],"Wikipedia":["Canertinib"],"drugbank":["DB05424"],"chEBI":["61399"]},"childChemblIds":["CHEMBL545315"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000178568","ENSG00000141736"],"count":3},"linkedDiseases":{"rows":["EFO_0003869","MONDO_0021117","EFO_0003060"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL323556","canonicalSmiles":"CC1CNCCN1S(=O)(=O)c1cccc2cnccc12","inchiKey":"BDVFVCGFMNCYPV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL323556","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124880257","124880258","26751761","56322739","855933","90341587"],"drugbank":["DB07996"],"chEBI":["43385"]},"childChemblIds":["CHEMBL540848","CHEMBL1256679"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL329985","canonicalSmiles":"CC(C)(C)c1ccc(Sc2cccc3nc(N)nc(N)c23)cc1","inchiKey":"MNYDVPDMLAJJPB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL329985","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01958"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301675","canonicalSmiles":"C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@@H]2CSSC[C@H](N)C(=O)N[C@H]3CSSC[C@H](NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)CSSC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC3=O)C(=O)N2","inchiKey":"KXGCNMMJRFDFNR-WDRJZQOASA-N","drugType":"Protein","blackBoxWarning":true,"name":"LINACLOTIDE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Constella","Linzess"],"synonyms":["ASP-0456","ASP0456","Linaclotide","MD-1100"],"crossReferences":{"DailyMed":["linaclotide"],"drugbank":["DB08890"],"chEBI":["68551"]},"childChemblIds":["CHEMBL3301676"],"linkedTargets":{"rows":["ENSG00000070019"],"count":1},"linkedDiseases":{"rows":["EFO_0000555","EFO_0005406","HP_0012450","HP_0002019","EFO_1001951","MONDO_0002203"],"count":6},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 3 approved and 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3304486","canonicalSmiles":"CN(C)CC(C)(C)OC(=O)C(O)(c1ccccc1)c1ccccc1","inchiKey":"WJIZVQNUJVMJAZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIFEMERINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"year":1986},"tradeNames":[],"synonyms":["Difemerine"],"childChemblIds":["CHEMBL3301670"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for gastrointestinal disease. It was withdrawn in Germany  in 1986."}
{"id":"CHEMBL344159","canonicalSmiles":"Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc32)c(C)c1","inchiKey":"GYHCTFXIZSNGJT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TOLVAPTAN","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Jinarc","Jynarque","Samsca"],"synonyms":["OPC-41061","OPC-41061(TOLVAPTAN)","Tolvaptan"],"crossReferences":{"DailyMed":["tolvaptan"],"PubChem":["124894207","144206807"],"Wikipedia":["Tolvaptan"]},"linkedTargets":{"rows":["ENSG00000126895"],"count":1},"linkedDiseases":{"rows":["HP_0002094","EFO_0003086","EFO_0008620","EFO_1001771","EFO_0000313","EFO_0000319","EFO_0000373","EFO_1001496","EFO_0000311","EFO_0001422","MONDO_0020642","HP_0002902","EFO_0003144","EFO_0004253","EFO_0003884","EFO_1000982"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 5 approved and 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3545012","drugType":"Small molecule","blackBoxWarning":false,"name":"DSP-2230","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dsp-2230"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545299","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-698769","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-698769"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545325","drugType":"Small molecule","blackBoxWarning":false,"name":"SAR-125844","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SAR 125844","SAR-125844","SAR125844","Sar-125844"],"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3707209","canonicalSmiles":"CCCC(C)(CCO[N+](=O)[O-])O[N+](=O)[O-]","inchiKey":"SNMKANWYFGWYCK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLPROPYLPROPANEDIOL DINITRATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methylpropylpropanediol dinitrate"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707256","drugType":"Small molecule","blackBoxWarning":false,"name":"FERROUS ASPARTATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aspartic acid, iron (ii) salt","Ferrous aspartate","Givobio afedl","Spartocine"],"crossReferences":{"DrugCentral":["4541"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3833382","canonicalSmiles":"CCC[N+]12[C@H]3C[C@@]45c6ccccc6N(C)[C@H]4[C@@H]1C[C@@H]([C@H](CC)[C@H]2O)[C@H]3[C@H]5O","inchiKey":"UAUHEPXILIZYCU-GSPNQRMKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRAJMALIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["N-propylajmaline","Prajmaline","Prajmalium cation","Prajmalium ion"],"childChemblIds":["CHEMBL3833388"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiac arrhythmia."}
{"id":"CHEMBL395429","canonicalSmiles":"CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O","inchiKey":"XNOPRXBHLZRZKH-DSZYJQQASA-N","drugType":"Protein","blackBoxWarning":true,"name":"OXYTOCIN","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Orasthin","Oxytocin","Pitocin","Syntocinon","Syntometrine"],"synonyms":["Alpha-hypophamine","Endopituitrina","Intertocine s","Oxytocin","Oxytocinum","TNX-1900","TNX1900","TTA-121"],"crossReferences":{"DailyMed":["oxytocin"],"PubChem":["50112429"],"chEBI":["7872"]},"childChemblIds":["CHEMBL3185709"],"linkedTargets":{"rows":["ENSG00000180914"],"count":1},"linkedDiseases":{"rows":["EFO_0004777","EFO_0002610","MONDO_0002009","EFO_0003768","EFO_1001917","EFO_0010642","EFO_1001271","EFO_1000911","EFO_0004714","EFO_0004616","EFO_0003877","EFO_0005762","EFO_0003888","EFO_0003756","Orphanet_48652","HP_0012532","EFO_0003758","MP_0001914","GO_0007568","MP_0001845","MONDO_0100096","EFO_0000432","EFO_0000668","MONDO_0002025","MONDO_0005090","EFO_0004566","Orphanet_282","EFO_0008507","EFO_1000948","EFO_0009579","EFO_0002950","EFO_0004247","Orphanet_739","MONDO_0002050","EFO_1000096","MONDO_0007079","EFO_0004242","EFO_0005230","EFO_0004215","EFO_0004269","EFO_0009658","EFO_0001358","EFO_0010702","EFO_0010445","EFO_0001073","EFO_0003843","Orphanet_908","EFO_0001072","EFO_0003890","MONDO_0002491","MONDO_0004782","EFO_0000612","EFO_0005611","EFO_1001863","EFO_0003918","EFO_0005411","MONDO_0005178"],"count":57},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and is indicated for hemorrhage and uterine inertia and has 47 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989568","canonicalSmiles":"CN(C)[C@@H]1C([O-])=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12.CN(C)[C@@H]1C([O-])=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12.[Ca+2]","inchiKey":"KIPLYOUQVMMOHB-MXWBXKMOSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYTETRACYCLINE CALCIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1517","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Terramycin"],"synonyms":["Calcium dioxytetracycline","Oxytetracycline calcium","Oxytetracycline hemicalcium"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and has 1 investigational indication."}
{"id":"CHEMBL406291","canonicalSmiles":"N=C(N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O","inchiKey":"QXZGBUJJYSLZLT-FDISYFBBSA-N","drugType":"Protein","blackBoxWarning":false,"name":"BRADYKININ","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BRS-640","Bradykinin","Callidin i","Kallidin i","Kallidin-9"],"crossReferences":{"PubChem":["50112435"],"Wikipedia":["Bradykinin"],"drugbank":["DB12126"],"chEBI":["3165"]},"description":"Protein drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL416","canonicalSmiles":"COc1c2occc2cc2ccc(=O)oc12","inchiKey":"QXKHYNVANLEOEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METHOXSALEN","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["8-mop","Deltasoralen","Meladinine","Methoxsalen","Oxsoralen","Oxsoralen-ultra","Puvasoralen-8","Uvadex"],"synonyms":["8-methoxsalen","8-methoxypsoralen","Methoxsalen","Metoxalen","NSC-45923","Oxypsoralen","Puvalen","SM-88 COMPONENT METHOXSALEN","Vitpso","Xanthotoxin"],"crossReferences":{"DailyMed":["methoxsalen"],"PubChem":["104171301","11112313","144203983","144208965","144213133","170465041","17389831","174006539","26752292","4255217","50105146","99459"],"Wikipedia":["Methoxsalen"],"drugbank":["DB00553"],"chEBI":["18358"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1954 and is indicated for t-cell non-hodgkin lymphoma and psoriasis and has 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4297389","canonicalSmiles":"O=C1[C@H](C/C=C(\\CO)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1","inchiKey":"HEHHPZYUXSFAPV-SMOXZEHUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYZETIMIBE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HS-25","Hs-25","Hyzetimibe"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297403","canonicalSmiles":"CCOC(=O)[C@H](Cc1ccc(F)cc1)NC(=O)[C@@H](N)Cc1ccc(N(CCCl)CCCl)cc1.Cl","inchiKey":"ZCMWSKHHXLCVHI-VROPFNGYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MELPHALAN FLUFENAMIDE HYDROCHLORIDE","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL4303060","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pepaxto"],"synonyms":["CK 1535","CK-1535","J-1 HYDROCHLORIDE","J1 hydrochloride ","Melflufen","Melflufen hydrochloride","Melphalan flufenamide hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and is indicated for multiple myeloma and has 2 investigational indications."}
{"id":"CHEMBL4297576","drugType":"Protein","blackBoxWarning":false,"name":"EFINOPEGDUTIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Efinopegdutide","HM-12525A","HM12525A","JNJ-64565111","Jnj-64565111"],"linkedTargets":{"rows":["ENSG00000112164","ENSG00000215644"],"count":2},"linkedDiseases":{"rows":["EFO_0003884","EFO_1001249","MONDO_0005148","EFO_0001073"],"count":4},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297627","canonicalSmiles":"C[C@@H]1CCc2ncc(F)cc2[C@H]2CCCN2c2ccn3ncc(c3n2)C(=O)N1","inchiKey":"OEBIHOVSAMBXIB-SJKOYZFVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELITRECTINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LOXO-195","Loxo-195","Selitrectinib"],"crossReferences":{"drugbank":["DB14896"]},"linkedTargets":{"rows":["ENSG00000140538","ENSG00000148053","ENSG00000198400"],"count":3},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297776","drugType":"Unknown","blackBoxWarning":false,"name":"LEFITOLIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lefitolimod","MGN-1703","TLR9 AGONIST MGN1703"],"linkedTargets":{"rows":["ENSG00000239732"],"count":1},"linkedDiseases":{"rows":["EFO_0000180"],"count":1},"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL444633","canonicalSmiles":"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\\C=C\\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O","inchiKey":"ATEBXHFBFRCZMA-VXTBVIBXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIFABUTIN","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mycobutin","Rifabutin"],"synonyms":["Ansamycin","LM 427","LM-427","MYCOBUTIN","Rifabutin"],"crossReferences":{"DailyMed":["rifabutin"],"PubChem":["144204563","144207956"],"Wikipedia":["Rifabutin"],"drugbank":["DB00615"],"chEBI":["45367"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 4 approved and 6 investigational indications."}
{"id":"CHEMBL4594535","drugType":"Antibody","blackBoxWarning":false,"name":"SUGEMALIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CS-1001","CS1001","Cs1001","Sugemalimab","WBP-315","WBP315"],"linkedTargets":{"rows":["ENSG00000120217"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000503","EFO_0000182","EFO_0000702","EFO_0000574","MONDO_0003219","EFO_0000183","EFO_0003060","EFO_0000311"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL4594571","drugType":"Unknown","blackBoxWarning":false,"name":"LU AF-82422","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AF-82422","LU AF-82422","LU AF82422","Lu af-82422","Lu af82422"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL460910","canonicalSmiles":"Cc1cn([C@H]2C[C@H](O)[C@@H](CN3CCCCC3)O2)c(=O)[nH]c1=O","inchiKey":"GMOUOGHZJCSNOZ-YNEHKIRRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL460910","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08596"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL463321","canonicalSmiles":"CCCCCC(=O)CC(=O)N[C@H]1CCOC1=O","inchiKey":"FXCMGCFNLNFLSH-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL463321","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08081"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL464982","canonicalSmiles":"CCCCC/C=C\\C/C=C\\C/C=C\\CCCCC(=O)O","inchiKey":"VZCCETWTMQHEPK-QNEBEIHSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GAMOLENIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Efamast 40","Efamast 80","Epoc","Epogam","Epogam 40","Epogam 80","Epogam paed","Gam-o","Gammolin","Gamophase","Kentogam","Lin-gam","Unigam"],"synonyms":["(6z,9z,12z-octadecatrienoic acid",".gamma.-linolenic acid","18:3(N-6)","C18:3 (n-6)","Delta-linolenic acid","Gamma linolenic acid","Gamma-linolenate","Gammalinolenic acid","Gamolenic acid","Gamolenic-acid","NDI 609","Sonova 400"],"crossReferences":{"PubChem":["144205388","26754623","26754624","29216151","50110102","57260207"],"Wikipedia":["Gamma-Linolenic_acid"],"drugbank":["DB13854"],"chEBI":["28661"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650279","canonicalSmiles":"C=CC(=O)Nc1cc2c(Nc3ccc(OCc4ccccn4)c(Cl)c3)ncnc2cc1OCCN1CCOCC1","inchiKey":"HIBPKFXWOPYJPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BDTX189","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BDTX189","Bdtx-189","Bdtx189"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000141736"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650389","drugType":"Unknown","blackBoxWarning":false,"name":"DECORIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bone proteoglycan ii","Decorin","Pg-s2"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650395","drugType":"Antibody","blackBoxWarning":false,"name":"GLENZOCIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACT-017","ACT017","Glenzocimab"],"linkedTargets":{"rows":["ENSG00000088053"],"count":1},"linkedDiseases":{"rows":["HP_0002140"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650420","drugType":"Protein","blackBoxWarning":false,"name":"RECIFERCEPT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Recifercept","Ta-46"],"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL46778","canonicalSmiles":"O=CNC1CCCCC1","inchiKey":"SWGXDLRCJNEEGZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOHEXYLFORMAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-Cyclohexyl-Formamide"],"crossReferences":{"drugbank":["DB03559"],"chEBI":["17945"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL46817","canonicalSmiles":"Cc1nc(C)c(-c2ccnc(Nc3ccc(N(C)C)cc3)n2)s1","inchiKey":"FGGSNQOBRJVAKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL46817","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07562"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4802152","canonicalSmiles":"O=C(c1cc(Cn2c(=O)[nH]c(=O)c3c(F)cccc32)ccc1F)N1CCN(c2ncccn2)CC1","inchiKey":"VBTUJTGLLREMNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SENAPARIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMP-4297","IMP4297","Imp4297","Senaparib"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL485747","canonicalSmiles":"OCCCc1ccc(O)c(O)c1","inchiKey":"DPTPQXXDBLPEOP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYTYROSOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Homoprotocatechuyl alcohol","Hydroxytyrosol"],"crossReferences":{"PubChem":["24841446"],"Wikipedia":["Hydroxytyrosol"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL487253","canonicalSmiles":"Cn1c(CCCC(=O)O)nc2cc(N(CCCl)CCCl)ccc21","inchiKey":"YTKUWDBFDASYHO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENDAMUSTINE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bendamustine"],"crossReferences":{"DailyMed":["bendamustine%20hydrochloride"],"PubChem":["144206324","170465340","174007431","50125886"],"Wikipedia":["Bendamustine"],"drugbank":["DB06769"]},"childChemblIds":["CHEMBL1201734"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 5 approved and 36 investigational indications."}
{"id":"CHEMBL501174","canonicalSmiles":"CC(C)=CCC/C(C)=C/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C=C(\\C)CCC=C(C)C","inchiKey":"OAIJSZIZWZSQBC-GYZMGTAESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LYCOPENE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(all-e)-lycopene","(all-trans)-lycopene","Aec lycopene","Ateronon","Blakeslea trispora","Ci 75125","E-160D(III)","E160d","FEMA NO. 4110","INS NO.160D(III)","INS-160D(III)","Lycopene","Lycopene from blakeslea trispora","Lycopene preparation","Lycored","Mexoryl saq","NSC-407322","Redivivo","Tomat-o-red","Tomato lycopene"],"crossReferences":{"PubChem":["144205948","29218049"],"Wikipedia":["Lycopene"],"drugbank":["DB11231"],"chEBI":["15948"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL509","canonicalSmiles":"Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl","inchiKey":"SBDNJUWAMKYJOX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MECLOFENAMIC ACID","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CI-583","CL-583","INF 4668","INF-4668","Meclodium","Meclofenamate","Meclofenamic acid","Meclomen","NSC-95309"],"crossReferences":{"DailyMed":["meclofenamate%20sodium"],"PubChem":["24424562","26751537","90341585"],"Wikipedia":["Meclofenamic_acid"],"drugbank":["DB00939"],"chEBI":["6710"]},"childChemblIds":["CHEMBL1562610","CHEMBL876"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000012779","ENSG00000095303"],"count":3},"linkedDiseases":{"rows":["HP_0002829","HP_0003326","EFO_0000685","HP_0001945","HP_0100607","MONDO_0005178","EFO_0005755","EFO_0002609"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and has 8 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL518924","canonicalSmiles":"NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc21","inchiKey":"WVLHHLRVNDMIAR-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAVORIXAFOR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMD-070","AMD-11070","AMD070","AMD11070","Amd 070","Amd070","Cxcr4 inhibitor x4p-001","Mavorixafor","X 4P-001","X4P-001","X4p001"],"crossReferences":{"drugbank":["DB05501"]},"childChemblIds":["CHEMBL4203190"],"linkedTargets":{"rows":["ENSG00000121966"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","Orphanet_51636","MONDO_0001475","EFO_0000756","EFO_0000764","EFO_0000349","MONDO_0007254"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL52440","canonicalSmiles":"COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3","inchiKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTROMETHORPHAN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dextromethorphan","Dimetane-DX","NSC-751452"],"crossReferences":{"DailyMed":["dextromethorphan%20hydrobromide"],"PubChem":["11111057","50100218"],"Wikipedia":["Dextromethorphan"],"drugbank":["DB00514"]},"childChemblIds":["CHEMBL1201461","CHEMBL3989946","CHEMBL3989940","CHEMBL1201004","CHEMBL1256818"],"linkedTargets":{"rows":["ENSG00000183454","ENSG00000147955"],"count":2},"linkedDiseases":{"rows":["EFO_0000729","MONDO_0005090","EFO_0005687","EFO_0007486","HP_0012735","MONDO_0002009","EFO_0000555","Orphanet_232","EFO_1001919","MONDO_0005271","Orphanet_778","Orphanet_68380","MONDO_0005277","HP_0100543","EFO_0004247","EFO_0000289","MONDO_0002050","EFO_0009430","EFO_1000783","EFO_0000544","EFO_0003100","MONDO_0005180","EFO_0000676","EFO_0002460","MONDO_0004976","EFO_0009321","HP_0000737","EFO_0002617","EFO_0005762","EFO_0000616","HP_0000093","HP_0001945","EFO_0005772","EFO_0009692","EFO_0003758","EFO_0003929","HP_0001742","EFO_0003843","HP_0002315","EFO_0007214","MONDO_0008315","EFO_0000384","EFO_0001663","EFO_0003890","EFO_0001068","MONDO_0005301","EFO_0000764","MONDO_0004975","MONDO_0004979","EFO_0005611","MONDO_0005148","EFO_0001062"],"count":52},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 7 approved and 38 investigational indications."}
{"id":"CHEMBL549","canonicalSmiles":"CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21","inchiKey":"WSEQXVZVJXJVFP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CITALOPRAM","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Celexa","Citadur","Citalopram"],"crossReferences":{"DailyMed":["citalopram%20hydrobromide"],"PubChem":["174007166","50104852","90340852"],"Wikipedia":["Citalopram"],"drugbank":["DB00215"],"chEBI":["77397"]},"childChemblIds":["CHEMBL1628605","CHEMBL1200781"],"linkedTargets":{"rows":["ENSG00000108576"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0003756","Orphanet_282","EFO_0002610","EFO_0004262","MONDO_0002009","EFO_0000555","HP_0000726","EFO_0003758","HP_0031217","Orphanet_95","HP_0000713","MONDO_0002046","EFO_0003948","EFO_0000289","MONDO_0002050","MONDO_0005180","EFO_0000712","EFO_0003761","EFO_0005611","HP_0100749","EFO_0004242","MONDO_0007079","EFO_0005230","EFO_0005672"],"count":25},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 3 approved and 19 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL612","canonicalSmiles":"C[C@H](N)Cc1ccccc1","inchiKey":"KWTSXDURSIMDCE-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DEXTROAMPHETAMINE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dexedrine","Dextrostat"],"synonyms":["Amfetamine, (s)-","Amphetamine, d-","D-amphetamine","Dexamfetamine","Dexampex","Dexamphetamine","Dexedrine","Dexidrine","Dextroamphetamine","Dextroamphetamine resin complex","Dextrostat","Ferndex","NSC-73713"],"crossReferences":{"DailyMed":["dextroamphetamine%20saccharate","dextroamphetamine%20sulfate"],"PubChem":["50113060"],"Wikipedia":["Dextroamphetamine"],"drugbank":["DB01576"],"chEBI":["4469"]},"childChemblIds":["CHEMBL1200782","CHEMBL287386","CHEMBL2106669","CHEMBL3544971","CHEMBL3989844"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319","ENSG00000165646"],"count":3},"linkedDiseases":{"rows":["EFO_0003888","MONDO_0005090","EFO_0002610","EFO_0010445","EFO_0001073","EFO_0000289","EFO_0003890","MONDO_0002050","MONDO_0005301","MONDO_0002277","EFO_0000712","EFO_0000326","EFO_0005611","MONDO_0016158","EFO_0004701"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and has 5 approved and 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL6367","canonicalSmiles":"CCC(C)(C)C(=O)C(=O)N1CCC[C@H]1C(=O)OCCCc1cccnc1","inchiKey":"OQAHHWOPVDDWHD-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GPI-1046","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GPI-1046"],"crossReferences":{"drugbank":["DB01951"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL637","canonicalSmiles":"COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1","inchiKey":"PNVNVHUZROJLTJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VENLAFAXINE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alventa xl","Amphero xl","Bonilux xl","Depefex xl","Efexor","Efexor xl","Foraven xl","Mentaven xl","Politid xl","Ranfaxine xl","Rodomel xl","Sunveniz xl","Tardcaps xl","Tifaxin xl","Tonpular xl","Trixat xl","Vaxalin xl","Venaxx xl","Venlablue xl","Venladex xl","Venlalic xl","Venlaneo xl","Vensir xl","Vexarin xl","Viepax","Viepax xl","Winfex xl"],"synonyms":["Efectin","Effexor","Kanghong","NSC-758676","Trevilor","Velafax","Venlafaxine","Venlor"],"crossReferences":{"DailyMed":["venlafaxine%20hydrochloride"],"PubChem":["144204978","170465123","174007175","26748923","90341232"],"Wikipedia":["Venlafaxine"],"drugbank":["DB00285"],"chEBI":["9943"]},"childChemblIds":["CHEMBL1201066","CHEMBL3133301"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["EFO_0006862","MONDO_0005090","EFO_0002610","EFO_0004262","EFO_0005687","MONDO_0002009","HP_0000726","EFO_1001919","MONDO_0007254","EFO_1002014","EFO_1001917","HP_0031217","MONDO_0005277","EFO_0000289","MONDO_0002050","MONDO_0005180","EFO_0000673","EFO_0003761","EFO_0009854","EFO_0004242","EFO_0005230","EFO_0005762","EFO_0006788","EFO_0001358","MONDO_0008315","EFO_1001892","HP_0030833","MONDO_0004975","MONDO_0043510","EFO_0003918"],"count":30},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 8 approved and 20 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL83626","canonicalSmiles":"CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(OC(=O)CCC(=O)O)c(C(C)(C)C)c1","inchiKey":"RKSMVPNZHBRNNS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUCCINOBUCOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGI-1067","Succinobucol"],"crossReferences":{"drugbank":["DB05399"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL87543","canonicalSmiles":"CC(C)N1CCC(N(C(=O)Cc2ccccc2)c2ccc(Cl)cc2)CC1","inchiKey":"XHOJAWVAWFHGHL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LORCAINIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lorcainide","RO 13-1042","RO-13-1042"],"crossReferences":{"Wikipedia":["Lorcainide"],"drugbank":["DB13653"]},"childChemblIds":["CHEMBL3085477"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL931","canonicalSmiles":"FC(F)(F)C(Cl)Br","inchiKey":"BCQZXOMGPXTTIC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HALOTHANE","yearOfFirstApproval":1958,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fluothane","Halothane","Rhidialothan"],"synonyms":["FREON 123B1","Halothane","Halothanum","NSC-143490"],"crossReferences":{"PubChem":["144204584","144208048","170464645","17388981"],"Wikipedia":["Halothane"],"drugbank":["DB01159"],"chEBI":["5615"]},"childChemblIds":["CHEMBL3250431"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1958."}
{"id":"CHEMBL94061","canonicalSmiles":"CN(C)C/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1","inchiKey":"ZCIXBBSRVLSRJQ-QPJJXVBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL94061","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08564"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL9967","canonicalSmiles":"CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1","inchiKey":"RMHMFHUVIITRHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRENZEPINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gastri p","Gastrozepin"],"synonyms":["ACI-91","Pirenzepine"],"crossReferences":{"PubChem":["104171218","11111661","11111662","11113363","144203790","170465793","26751604","90341394"],"Wikipedia":["Pirenzepine"],"drugbank":["DB00670"],"chEBI":["8247"]},"childChemblIds":["CHEMBL1257024","CHEMBL1531864"],"linkedTargets":{"rows":["ENSG00000168539"],"count":1},"linkedDiseases":{"rows":["HP_0004398","EFO_0003948"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for peptic ulcer and gastroesophageal reflux disease."}
